Log In
BCIQ
Print this Print this
 

ortataxel (SPI-5109), 14-beta-hydroxydeacetylbaccatin (formerly IDN 5109)

  Manage Alerts
Collapse Summary General Information
Company Indena S.p.A.
DescriptionThird-generation taxane
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerSpectrum Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today